Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models
Figure 5
Treatment with the human CRP-specific ASO ISIS 353512 improves blood vessel patency following RCCA ligation in CRPtg mice (a) but not in wild-type mice (b). Blood vessel patency was calculated as described in the Materials and Methods. The asterisks indicate for unpaired t-tests.
